17 Oct 2025 | 3 Mins Read
Strides Pharma partners with Incepta for long-acting contraceptive launch
Flipitmoney
Strides Pharma Science Ltd. partnered with Incepta Pharmaceuticals to launch the world's first WHO-prequalified generic version of subcutaneous depot medroxyprogesterone acetate (DMPA-SC), a three-month injectable contraceptive. The branded product, Medogen SubQ, aims to expand access to modern contraception in low- and middle-income countries.